Trial Profile
Long-Term Safety Study of Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jun 2009
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Wyeth
- 09 Jun 2009 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 09 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Nov 2006 New trial record.